If you’ve ever hoped for a new treatment for hair loss, you will want to pay attention to this. The experimental drug VDPHL01 has shown promise in a phase 3 clinical trial for men, who saw visible hair growth over six months. However, before we get too excited about this treatment, we need to warn you it has not yet been given the green light by the FDA.
So, What Is This New Hair-Loss Drug?
VDPHL01 is an oral tablet for patients with pattern hair loss, a typical hair-loss condition that leads to permanent hair loss over time. The tablet contains extended-release Minoxidil, which is a component of currently marketed hair-loss treatments. The ingredient is released slowly rather than immediately, which could promote hair growth and minimize side effects.
What Did the Latest Trial Actually Find?
In a Phase 3 trial of 536 men, they tested two dosing regimens against a placebo, a tablet with no active drug. After six months, the men on VDPHL01 experienced a mean increase of roughly 29 to 36 hairs per sq cm of the measured area of scalp, compared with around seven hairs on the placebo. The men also on the drug experienced a greater increase in hair coverage. This is promising, but does not guarantee an individual, of course.
Why Is the Extended-Release Part Important?
Minoxidil is already an approved treatment that makes hair grow in some people, but if taken by mouth can also cause weight gain, increased heartbeat, or blood pressure to go up and down. VDPHL01 is formulated to deliver minoxidil to the body more slowly, to avoid these big spikes. Results in the current study are promising, but long-term trials will be needed to fully assess its safety.
Does This Mean the Pill Will Be Available Soon?
Not quite. Just because a Phase 3 trial is a win doesn’t mean the drug is likely to get approved. The regulators will need to sift through the data on how effective it is, its dangers, where the drug is made, and whether its benefits outweigh the harms. The drug is being tested for treatment in women as well, and its female pattern hair loss trial results are due in 2027.
Should People With Hair Loss Wait for This Drug?
Not always. Hair loss may be caused by pattern hair loss, thyroid dysfunction, other medical conditions, iron deficiency, or hormonal shifts. Knowing the right treatment means knowing the cause of the hair loss. A dermatologist can determine the cause of the hair loss before you buy something and pay for products or supplements. And, by the way, do not begin taking the oral form of minoxidil without a doctor’s supervision, because even prescription medications for hair growth can impact your heart and blood pressure.
VDPHL01 might be another option in the future if you’re suffering from pattern hair loss, and the new results give hope to scientists and developers to continue their search. However, trial success is not a validated medicine, and it does not suggest fantastic regrowth for everyone. For the present, it remains a positive development to watch, but it should not change the next steps for you with your current treatment.
Publisher: Source link
